Nitroxides as antioxidants- Possibilities of their application in chemoprevention and radioprotection;Nitroksydy jako antyoksydanty- Mozliwości ich zastosowania w celach chemioprewencyjnych oraz radioprotekcyjnych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 65, Issue , 2011, Pages 46-54

  Tabaczar, Sabina ^a   Talar, Marcin ^a   Gwoździński, Krzysztof ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Nitroxide; Oxidative stress; SOD mimics; Tempol

Indexed keywords

AMINE OXIDE; ANTIOXIDANT; NITROGEN OXIDE; RADIOPROTECTIVE AGENT; TEMPOL;

CHEMOPROPHYLAXIS; DRUG EFFECT; HUMAN; OXIDATIVE STRESS; REVIEW; SPIN LABELING;

ANTIOXIDANTS; CHEMOPREVENTION; CYCLIC N-OXIDES; HUMANS; NITROGEN OXIDES; OXIDATIVE STRESS; RADIATION-PROTECTIVE AGENTS; SPIN LABELS;

EID: 79958803705     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.932256     Document Type: Review

References (85)

1. Allen R.G., Tresini M.: Oxidative stress and gene regulation. Free Radic. Biol. Med., 2000; 28: 463-499. (Pubitemid 30110662)
2. Barcellos-Hoff M.H.: How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat. Res., 1998; 150(Suppl.5): S109-S120. (Pubitemid 28519056)
3. Barzilai A., Rotman G., Shiloh Y.: ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair, 2002; 1: 3-25. (Pubitemid 34475690)
4. Bobko A.A., Kirilyuk I.A., Grigor'ev I.A., Zweier J.L., Khramtsov V.V.: Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione. Free Radic. Biol. Med., 2007; 42: 404-412. (Pubitemid 46038046)
5. Buettner G.R., Ng C.F., Wang M., Rodgers V.G., Schafer F.Q.: A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med., 2006; 41: 1338-1350. (Pubitemid 44479829)
6. Bujak S., Gwozdzinski K.: Nitroxides lead to reduced level of glutathione in red blood cells. In: Free Radical and oxidative stress: Chemistry and Pathological implications, ed.: G. Galaris, Medimond International Proceedings, 2003; 105-108.
7. Bujak S., Gwozdzinski K.: The effect of stable nitroxide radicals on the activity of glutathione-dependent enzymes: reductase, peroxidase and transferase in human erythrocyte. Society for Free Radical Research International, Proceedings of the XIII Congress, Medimont S.r.l, 2006; 71-74.
8. Catalá A.: Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids, 2009; 157: 1-11.
9. Cimato A.N., Piehl L.L., Facorro G.B., Torti H.B., Hager A.A.: Antioxidant effects of water- and lipid-soluble nitroxide radicals in liposomes. Free Radic. Biol. Med., 2004; 37: 2042-2051. (Pubitemid 39491323)
10. Citrin D., Cotrim A.P., Hyodo F., Baum B.J., Krishna M.C., Mitchell J.B.: Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist, 2010; 15: 360-371.
11. Cotrim A.P., Hyodo F., Matsumoto K., Sowers A.L., Cook J.A., Baum B.J., Krishna M.C., Mitchell J.B.: Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin. Cancer Res., 2007; 13: 4928-4933. (Pubitemid 47294801)
12. Couet W.R., Brasch R.C., Sosnovsky G., Tozer T.N.: Factors affecting nitroxide reduction in ascorbate solution and tissue homogenates. Magn. Reson. Imaging, 1985; 3: 83-88. (Pubitemid 15075066)
13. Cuscela D., Coffin D., Lupton G.P., Cook J.A., Krishna M.C., Bonner R.F., Mitchell J.B.: Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies. Cancer J. Sci. Am., 1996; 2: 273-278.
14. Czepas J., Koceva-Chyla A., Gwozdzinski K., Józwiak Z.: Different effectiveness of piperidine nitroxides against oxidative stress induced by doxorubicin and hydrogen peroxide. Cell Biol. Toxicol., 2008; 24: 101-112.
15. DeGraff W.G., Krishna M.C., Kaufman D., Mitchell J.B.: Nitroxide-mediated protection against X-ray- and neocarzinostatin-induced DNA damage. Free Radic. Biol. Med., 1992; 13: 479-487.
16. Deres P., Halmosi R., Toth A., Kovacs K., Palfi A., Habon T., Czopf L., Kalai T., Hideg K., Sumegi B., Toth K.: Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J. Cardiovasc. Pharmacol., 2005; 45: 36-43. (Pubitemid 40039753)
17. Erker L., Schubert R., Yakushiji H., Barlow C., Larson D., Mitchell J.B., Wynshaw-Boris A.: Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum. Mol. Genet., 2005; 14: 1699-1708. (Pubitemid 40895522)
18. Gallez B., Mäder K., Swartz H.M.: Noninvasive measurement of the pH inside the gut by using pH-sensitive nitroxides. An in vivo EPR study. Magn. Reson. Med., 1996; 36: 694-697. (Pubitemid 26376707)
19. Giulivi C., Cadenas E.: Ferrylmyoglobin: formation and chemical reactivity toward electron-donating compounds. Methods Enzymol., 1994; 233: 189-202.
20. Głȩbska J., Gwoździński K.: Nitroxides as protectors against oxidative damage induced by the Fenton system. Curr. Top. Biophys., 2000; 24: 57-63.
21. Głȩbska J., Skolimowski J., Kudzin Z., Gwoździnski K., Grzelak A., Bartosz G.: Prooxidative activity of nitroxides in their reactions with glutathione. Free Radic. Biol. Med., 2003; 35: 310-316. (Pubitemid 37288931)
22. Goffman T., Cuscela D., Glass J., Hahn S., Krishna C.M., Lupton G., Mitchell J.B.: Topical application of nitroxide protects radiation-induced alopecia in guinea pigs. Int. J. Radiat. Oncol. Biol. Phys., 1992; 22: 803-806.
23. Goldstein S., Merenyi G., Russo A., Samuni A.: The role of oxoammonium cation in the SOD-mimic activity of cyclic nitroxides. J. Am. Chem. Soc., 2003; 125: 789-795. (Pubitemid 36109941)
24. Goldstein S., Samuni A., Hideg K., Merenyi G.: Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. J. Phys. Chem. A, 2006; 110: 3679-3685.
25. Grinberg L.N., Samuni A.: Nitroxide stable radical prevents primaquine-induced lysis of red blood cell. Biochim. Biophys. Acta, 1994; 1201: 284-288.
26. Gueven N., Luff J., Peng C., Hosokawa K., Bottle S.E., Lavin M.F.: Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic. Biol. Med., 2006; 41: 992-1000. (Pubitemid 44247555)
27. Gwoździnski K., Bartosz G.: Nitroxides reduction in human red blood cells. Curr. Top. Biophys., 1996; 20(Suppl.): 60-65.
28. Gwoździński K., Bartosz G., Leyko W.: Effect of gamma radiation on the transport of spin-labeled compounds across the erythrocyte membrane. Radiat. Environ. Biophys., 1981; 19: 275-285. (Pubitemid 11050853)
29. Gwoździnski K., Bartosz G., Leyko W.: Effect of gamma radiation on the transport of non-electrolyte spin labels across human erythrocyte. Stud. Biophys., 1981; 86: 187-192.
30. Gwoździnski K., Bartosz G., Leyko W.: Effect of gamma radiation on the transport of electrolyte spin labels across human erytrocyte. Stud. Biophys. 1982; 89: 141-145.
31. Hahn S.M., Krishna M.C., DeLuca A.M., Coffin D., Mitchell J.B.: Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic. Biol. Med., 2000; 28: 953-958. (Pubitemid 30235169)
32. Hahn S.M., Sullivan F.J., DeLuca A.M., Krishna C.M., Wersto N., Venzon D., Russo A., Mitchell J.B.: Evaluation of tempol radioprotection in a murine tumor model. Free Radic. Biol. Med., 1997; 22: 1211-1216. (Pubitemid 27171963)
33. Hahn S.M., Tochner Z., Krishna C.M., Glass J., Wilson L., Samuni A., Sprague M., Venzon D., Glatstein E., Mitchell J.B., Russo A.: Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res., 1992; 52: 1750-1753.
34. Hahn S.M., Wilson L., Krishna C.M., Liebmann J., DeGraff W., Gamson J., Samuni A., Venzon D., Mitchell J.B.: Identification of nitroxide radioprotectors. Radiat. Res., 1992; 132: 87-93.
35. Halliwell B.: Vitamin C: poison, prophylactic or panacea? Trends Biochem. Sci., 1999; 24: 255-259. (Pubitemid 29301686)
36. Halliwell B.: Oxidative stress and cancer: have we moved forward? Biochem. J., 2007; 401: 1-11. (Pubitemid 46115897)
37. Hyodo F., Chuang K.H., Goloshevsky A.G., Sulima A., Griffiths G.L., Mitchell J.B., Koretsky A.P., Krishna M.C.: Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J. Cereb. Blood Flow Metab., 2008; 28: 1165-1174. (Pubitemid 351733355)
38. Iannone A., Bini A., Swartz H.M., Tomasi A., Vannini V.: Metabolism in rat liver microsomes of the nitroxide spin probe tempol. Biochem. Pharmacol., 1989; 38: 2581-2586. (Pubitemid 19201974)
39. Iannone A., Hu H.P., Tomasi A., Vannini V., Swartz H.M.: Metabolism of aqueous soluble nitroxides in hepatocytes: effects of cell integrity, oxygen, and structure of nitroxides. Biochim. Biophys. Acta, 1989; 991: 90-96. (Pubitemid 19102761)
40. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J.: Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 1997; 275: 1649-1652. (Pubitemid 27120541)
41. Irwin J.A., Ostdal H., Davies M.J.: Myoglobin-induced oxidative damage: evidence for radical transfer from oxidized myoglobin to other proteins and antioxidants. Arch. Biochem. Biophys., 1999; 362: 94-104. (Pubitemid 29391655)
42. Kato N., Yanaka K., Hyodo K., Homma K., Nagase S., Nose T.: Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia. Brain Res., 2003; 979: 188-193. (Pubitemid 36792169)
43. Kirilyuk I.A., Bobko A.A., Grigor'ev I.A., Khramtsov V.V.: Synthesis of the tetraethyl substituted pH-sensitive nitroxides of imidazole series with enhanced stability towards reduction. Org. Biomol. Chem., 2004; 2: 1025-1030.
44. Koceva-Chyła A., Gwoździnski K., Kochman A., Stolarska A., Jóźwiak Z.: Effects of pyrroline and pyrrolidine nitroxides on lipid peroxidation in heart tissue of rats treated with doxorubicin. Cell. Mol. Biol. Lett. 2003; 8: 179-183. (Pubitemid 36534580)
45. Koceva-Chyła A., Kochman A., Głȩbska J., Gwoździński K., Jóźwiak Z., Metodiewa D.: Tempicol-3, a novel piperidine-N-oxide stable radical and antioxidant, with low toxicity acts as apoptosis inducer and cell proliferation modifier of Yoshida Sarcoma cells in vivo. Anticancer Res., 2000; 20: 4611-4618. (Pubitemid 32143726)
46. Krishna M.C., DeGraff W., Hankovszky O.H., Sár C. P., Kálai T., Jeko J., Russo A., Mitchell J.B., Hideg K.: Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J. Med. Chem., 1998; 41: 3477-3492. (Pubitemid 28406556)
47. Krishna M.C., Grahame D.A., Samuni A., Mitchell J.B., Russo A.: Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc. Natl. Acad. Sci. USA, 1992; 89: 5537-5541.
48. Krishna M.C., Russo A., Mitchell J.B., Goldstein S., Dafni H., Samuni A.: Do nitroxide antioxidants act as scavengers of O2 - or as SOD mimics? J. Biol. Chem., 1996; 271: 26026-26031. (Pubitemid 26347441)
49. Krishna M.C., Samuni A.: The effect of oxygen at physiological levels on the detection of free radical intermediates by electron paramagnetic resonance. Free Radic. Res. Commun., 1993; 18: 239-247.
50. Krishna M.C., Samuni A., Taira J., Goldstein S., Mitchell J.B., Russo A.: Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J. Biol. Chem. 1996; 271: 26018-26025. (Pubitemid 26347440)
51. Kroll C., Langner A., Borchert H.H.: Nitroxide metabolism in the human keratinocyte cell line HaCaT. Free Radic. Biol. Med., 1999; 26: 850-857. (Pubitemid 29198357)
52. Kuppusamy P., Li H., Ilangovan G., Cardounel A.J., Zweier J.L., Yamada K., Krishna M.C., Mitchell J.B.: Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res., 2002; 62: 307-312. (Pubitemid 34074020)
53. Lewińska A., Wnuk M., Slota E., Bartosz G.: The nitroxide antioxidant Tempol affects metal-induced cyto- and genotoxicity in human lymphocytes in vitro. Mutat. Res., 2008; 649: 7-14. (Pubitemid 350235301)
54. Liebmann J., DeLuca A.M., Epstein A., Steinberg S.M., Morstyn G., Mitchell J.B.: Protection from lethal irradiation by the combination of stem cell factor and tempol. Radiat. Res., 1994; 137: 400-404. (Pubitemid 24098270)
55. Martínez R., Quintana K., Navarro R., Martín C., Hernández M.L., Aurrekoetxea I., Ruiz-Sanz J.I., Lacort M., Ruiz-Larrea M.B.: Pro-oxidant and antioxidant potential of catecholestrogens against ferrylmyoglobin-induced oxidative stress. Biochim. Biophys. Acta, 2002; 1583: 167-175. (Pubitemid 34765600)
56. Marx L., Chiarelli R., Guiberteau T., Rassat A.: A comparative study of the reduction by ascorbate of 1, 1, 3, 3-tetraethylisoindolin-2-yloxyl and of 1, 1, 3, 3-tetramethylisoindolin-2-yloxyl. J. Chem. Soc. Perkin Trans. 1, 2000; 8: 1181-1182. (Pubitemid 35290394)
57. Marzatico F., Porta C., Moroni M., Bertorelli L., Borasio E., Finotti N., Pansarasa O., Castagna L.: In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother. Pharmacol., 2000; 45: 172-176. (Pubitemid 30090249)
58. Matsumoto K., Krishna M.C., Mitchell J.B.: Novel pharmacokinetic measurement using electron paramagnetic resonance spectroscopy and simulation of in vivo decay of various nitroxyl spin probes in mouse blood. J. Pharmacol. Exp. Ther., 2004; 310: 1076-1083. (Pubitemid 39108929)
59. May J.M., Mendiratta S., Hill K.E., Burk R.F.: Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J. Biol. Chem., 1997; 272: 22607-22610. (Pubitemid 27386074)
60. McGarvey E.L., Baum L.D., Pinkerton R.C., Rogers L.M.: Psychological sequelae and alopecia among women with cancer. Cancer Pract., 2001; 9: 283-289. (Pubitemid 33032427)
61. 2 decomposition by peroxidases and pseudoperoxidases. Free Radic. Res. Commun., 1992; 17: 157-175.
62. Metodiewa D., Skolimowski J., Kochman A., Koceva-Chyla A.: The paradoxical apoptotic effects of novel nitroxide antioxidants on Yoshida sarcoma cells in vivo: a commentary. Anticancer Res., 2000; 20: 2593-2599. (Pubitemid 30614472)
63. Metz J.M., Smith D., Mick R., Lustig R., Mitchell J., Cherakuri M., Glatstein E., Hahn S.M.: A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin. Cancer Res., 2004; 10: 6411-6417. (Pubitemid 39346535)
64. Mitchell J.B., DeGraff W., Kaufman D., Krishna M.C., Samuni A., Finkelstein E., Ahn M.S., Hahn S.M., Gamson J., Russo A.: Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch. Biochem. Biophys., 1991; 289: 62-70.
65. Mitchell J.B., Samuni A., Krishna M.C., DeGraff W.G., Ahn M.S., Samuni U., Russo A.: Biologically active metal-independent superoxide dismutase mimics. Biochemistry, 1990; 29: 2802-2807. (Pubitemid 20122615)
66. Mitchell J.B., Xavier S., DeLuca A.M., Sowers A.L., Cook J.A., Krishna M.C., Hahn S.M., Russo A.: A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic. Biol. Med., 2003; 34: 93-102. (Pubitemid 36043890)
67. Miura Y., Utsumi H., Hamada A.: Antioxidant activity of nitroxide radicals in lipid peroxidation of rat liver microsomes. Arch. Biochem. Biophys., 1993; 300: 148-156. (Pubitemid 23225730)
68. Novak I., Harrison L.J., Kovac B., Pratt L.M.: Electronic structure of persistent radicals: nitroxides. J. Org. Chem., 2004; 69: 7628-7634. (Pubitemid 39405791)
69. Rassat A.: Application of electron spin resonance to conformational analysis. Pure Appl. Chem., 1971; 25: 623-634.
70. Riley P.A.: Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. J. Radiat. Biol., 1994; 65: 27-33. (Pubitemid 24063526)
71. Samuni A.M., Barenholz Y., Crommelin D.J., Zuidam N.J.: g-irradiation damage to liposomes differing in composition and their protection by nitroxides. Free Radic. Biol. Med., 1997; 23: 972-979. (Pubitemid 27451283)
72. Samuni A.M., DeGraff W., Cook J.A., Krishna M.C., Russo A., Mitchell J.B.: The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells. Free Radic. Biol. Med., 2004; 37: 1648-1655. (Pubitemid 39349811)
73. 2-induced damage and their protection by nitroxides. Biochim. Biophys. Acta, 2001; 1525: 70-76. (Pubitemid 32149979)
74. Schafer F.Q., Buettner G.R.: Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med., 2001; 30: 1191-1212. (Pubitemid 32463931)
75. Schubert R., Erker L., Barlow C., Yakushiji H., Larson D., Russo A., Mitchell J.B., Wynshaw-Boris A.: Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet., 2004; 13: 1793-1802. (Pubitemid 39173448)
76. Soule B.P., Hyodo F., Matsumoto K., Simone N.L., Cook J.A., Krishna M.C., Mitchell J.B.: The chemistry and biology of nitroxide compounds. Free Radic. Biol. Med., 2007; 42: 1632-1650. (Pubitemid 46617154)
77. Swartz H.M.: Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radic. Res. Commun., 1990; 9: 399-405. (Pubitemid 20376795)
78. Tada M., Yokoyama H., Ito O., Ohya H., Ogata T.: Evaluation of the hepatic reduction of a nitroxide radical in rats receiving ascorbic acid, glutathione or ascorbic acid oxidase by in vivo electron spin resonance study. J. Gastroenterol. Hepatol., 2004; 19: 99-105. (Pubitemid 38130614)
79. Ueda A., Nagase S., Yokoyama H., Tada M., Noda H., Ohya H., Kamada H., Hirayama A., Koyama A.: Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical. Mol. Cell. Biochem., 2003; 244: 119-124. (Pubitemid 36411062)
80. Villarini M., Moretti M., Damiani E., Greci L., Santroni A.M., Fedeli D., Falcioni G.: Detection of DNA damage in stressed trout nucleated erythrocytes using the comet assay: protection by nitroxide radicals. Free Radic. Biol. Med., 1998; 24: 1310-1315. (Pubitemid 28246747)
81. Vujaskovic Z., Anscher M.S., Feng Q.F., Rabbani Z.N., Amin K., Samulski T.S., Dewhirst M.W., Haroon Z.A.: Radiation-induced hypoxia may perpetuate late normal tissue injury. Int. J. Radiat. Oncol. Biol. Phys., 2001; 50: 851-855. (Pubitemid 32594826)
82. Woo R.A., Poon R.Y.: Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev., 2004; 18: 1317-1330. (Pubitemid 38720599)
83. Xavier S., Yamada K., Samuni A.M., Samuni A., DeGraff W., Krishna M.C., Mitchell J.B.: Differential protection by nitroxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim. Biophys. Acta, 2002; 1573: 109-120. (Pubitemid 35217932)
84. Zeltcer G., Berenshtein E., Kitrossky N., Chevion M., Samuni A.: Time window of nitroxide effect on myocardial ischemic-reperfusion injury potentiated by iron. Free Radic. Biol. Med. 2002; 32: 912-919. (Pubitemid 34439262)
85. Zhang Q.S., Eaton L., Snyder E.R., Houghtaling S., Mitchell J.B., Finegold M., Van Waes C., Grompe M.: Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res., 2008; 68: 1601-1608. (Pubitemid 351346870)